SERODUS AS
🏢 View company profile →3Patents
3Active
3Granted
57Portfolio score
Filing activity: Dec 23, 2004 → Nov 12, 2021 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8829028B2 | 5-HT4 receptor antagonists for the treatment of heart failure | Human Necessities | 3 | Active |
| US7834010B2 | Modulators of peripheral 5-HT receptors | Chemistry; Metallurgy | 2 | Active |
| US12083097B2 | Dual TNFR1 antagonists and TNER2 agonists for use in renal diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.